Title for MeetingAbstracts
Alphabetical listing of titles
GW433908 is associated with a significantly lower incidence of drug-related diarrhea and less use of antidiarrheals compared to nelfinavir in chronic HIV-infected antiretroviral therapy naive subjects.
Gw433908, a novel prodrug of the HIV protease inhibitor (PI) amprenavir (APV): safety, efficacy, and pharmacokinetics (PK) (APV20001).
GYN findings and HIV disease markers in a cohort of HIV positive women followed over time.
Gynaecological and reproductive aspects of HIV infected women.
Gynaecological problems in HIV positive women.
Gynaecomastia in HIV-infected men - association with effects of antiretroviral therapy.
Gynaecomastia in patients taking antiretroviral medications: A case series.
Gynecologic conditions in HIV-infected women in Brooklyn, New York.
Gynecologic findings and HIV positive patients: a one year period analysis.
Gynecologic findings in an HIV positive outpatient population.
Gynecologic findings in an HIV positive outpatient population: an update.
Gynecologic infection in women with HIV infection.
Gynecologic management of women in the Swiss HIV Cohort Study.
Gynecological care of the HIV-infected woman.
Gynecological findings and HIV related evaluation in a cohort of 75 patients.
Gynecological findings in HIV+ women in New Orleans.
Gynecological manifestations in early HIV disease, and screening Pap smears versus colposcopy.
Gynecological manifestations in HIV-positive patients.
Gynecological primary care in HIV disease.
Gynecological surgical outcomes among women infected with human immunodeficiency virus and uninfected control subjects.
Gynecologist approach to prevention and education about sexually transmitted diseases in Bogota, Colombia.
Gynecologist role in enhancing knowledge about sexually transmitted diseases (STDS) in Bogota, Colombia.
Gynecomastia associated with hypogonadism in HIV infected patients.
Gynecomastia emerging during antiretroviral therapy. What correlations have been explored?
GYNECOMASTIA IN HIV-INFECTED MALES: CAUSES, CLINICAL PRESENTATION AND OUTCOME.
gyrA or gyrB Mutations are Implicated in Cross-Resistance to Ciprofloxacin and Moxifloxacin in Clostridium Difficile.